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Summary 
Polyvinylpyrrolidone (PVP) and hyaluronic acid (HA) are routinely used in handling 
spermatozoa for intracytoplasmic sperm injection (ICSI). As there are still concerns about 
possible adverse effects on the embryo, this study investigated sperm handling in a mouse 
ICSI model to (i) evaluate oocyte activation after injection of spermatozoa selected for 
rotational or linear motion in PVP; (ii) assess the effect of sperm selection in PVP, HA and 
medium on oocyte activation; (iii) examine the effects of PVP and HA on parthenogenetic 
oocyte activation and embryo development; and (iv) assess the oxidation–reduction potential 
(ORP) of spermatozoa exposed to PVP, HA or medium. Oocyte activation was higher when 
spermatozoa exhibited rotational motion rather than linear motion (79% vs. 52%; p = .05). 
There was no difference in oocyte activation and embryo development after parthenogenetic 
oocyte activation after sperm injection using PVP, HA or medium-incubated spermatozoa. 
PVP-selected spermatozoa exhibited lower (p < .0001) ORP levels than using HA. Thus, 
results indicate that the sperm handling method and the type of medium used impact ICSI 
outcomes. Overall, sperm incubation in PVP, HA and medium yields similar outcomes with 
regard to oocyte activation and embryo development. However, PVP provides more 
antioxidative protection than HA and should therefore be preferred for sperm manipulation. 
 
1  |  Introduction 
Intracytoplasmic sperm injection (ICSI) is used to overcome severe male factor infertility, failed in 
vitro fertilisation (IVF) and unexplained infertility, among other conditions (Bungum, Bungum, 
Humaidan, & Andersen, 2004; Devroey & Van Steirteghem, 2004; Takeuchi et al., 2000). 
Fertilisation rates after sperm injection vary from 50% to 80% (Neri, Lee, Rosenwaks, Machaca, & 
Palermo, 2014), and these rates are dependent not only on oocyte quality but also on sperm quality 
and sperm source (Majumdar & Majumdar, 2013; Montag, Toth, & Strowitzki, 2012). As a matter 
of fact, insertion of the microinjection pipette into the oocyte cytoplasm by itself is not responsible 
for oocyte activation (Tesarik, Sousa, & Testart, 1994). 
 
For fertilisation to take place, spermatozoa must be able to activate the oocyte. Therefore, an 
integral laboratory aspect of ICSI is sperm selection, which is usually based on viability—often 
expressed by progressive or in situ motility and normal morphology (Montag et al., 2012). In 
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mouse oocytes, Kimura et al. (1998) reported that sperm-borne oocyte-activating factors (SOAF) 
appear during transformation of the round spermatid into the spermatozoon. However, the action of 
SOAF is not species-specific as mouse oocytes can be activated by injecting spermatozoa from 
foreign species, including hamster, rabbit, pig, human and fish. This is advantageous because unlike 
human oocytes, mouse oocytes are widely available and can be used in an experimental ICSI model. 
 
During the journey through the female reproductive tract and before reaching the oocyte, 
spermatozoa exhibit a variety of motility modes and swimming patterns, including linear as well as 
rotational motion or beat frequency (Hz) (Nosrati, Driouchi, Yip, & Sinton, 2015; Subramani, Basu, 
Thangaraju, & Dandekar, 2014). In order to facilitate the selection, handling and immobilisation of 
the male gamete prior to ICSI, post-washed sperm specimens are usually loaded into a microdroplet 
containing a viscous medium, such as polyvinylpyrroli-done (PVP) or hyaluronic acid (HA) that 
slowdown sperm movement. Increased medium viscosity dampens the strong linear component 
(Nosrati et al., 2015) and may convert sperm movement into rotational motion that is believed to 
be the result of a reversible change in the molecular components of the mitochondrial apparatus 
(Subramani et al., 2014). Nevertheless, it is at present unclear whether spermatozoa selected for ICSI 
displaying progressive and rotational motion into a PVP drop have better oocyte activation 
potential than those with progressive and nonrotational (linear) motion. This is an interesting 
concept that deserves further investigation because sperm rotational motion is easy to observe into 
the high viscosity media such as PVP using a regular inverted microscope (40×). 
 
Notwithstanding, concerns about the safety of PVP (Bourne et al., 1995) and its possible adverse 
impact on embryo development have also been raised (Kato & Nagao, 2012). It has been reported 
that spermatozoa selected in PVP exhibit a delay in calcium oscillations after oocyte injection, 
which may prevent nuclear decondensation (Clarke & Johnson, 1988; Dozortsev, Rybouchkin, De 
Sutter, Qian, & Dhont, 1995). Additionally, impairment in the development of two-cell mouse 
embryos (Bergers et al., 1993) and direct toxicity of PVP when injected into mouse zygotes (Bras, 
1994) was noted. On the contrary, PVP was noted to have no mutagenic potential as analysed by 
the frequency of sister chromatid exchange (Ray, Howell, Mcdermott, & Hull, 1995). Additionally, 
PVP was found harmless to the quality and development of bovine embryos (Motoishi, Goto, Tomita, 
Ookutsu, & Nakanishi, 1996). 
 
As HA-based products are commercially available, a few reports indicated that such medium might 
represent a good physiologic alternative to PVP (Balaban et al., 2003; Barak, Menezo, Veiga, & Elder, 
2001; Parmegiani, Cognigni, Bernardi, et al., 2010; Parmegiani, Cognigni, Ciampaglia, et al., 
2010). In vivo human oocytes are surrounded by HA and only the mature spermatozoa that have 
extruded specific HA receptors are able to reach and fertilise the oocyte (Parmegiani, Cognigni, 
Ciampaglia, et al., 2010). In vitro spermatozoa bound to HA are believed to be those that have 
completed plasma membrane remodelling, cytoplasmic extrusion, and nuclear maturation (Cayli et 
al., 2003; Huszar et al., 2007). However, the literature is mixed with regard to the advantage of using 
HA instead of PVP, therefore indicating the need for further studies (Balaban et al., 2003; Barak et al., 
2001; Choe et al., 2012; Majumdar & Majumdar, 2013). 
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After sperm injections, total fertilisation failure occurs in about 1%–3% cycles and the 
phenomenon can repeat in subsequent cycles (Flaherty, Payne, & Matthews, 1998; Kashir et al., 
2010). It has been hypothesised that total fertilisation failure might be due to a sperm-related oocyte 
activation deficiency (Flaherty et al., 1998; Neri et al., 2014; Swain & Pool, 2008; Yanagida, 2004). 
In this regard, mouse oocytes provide a useful model for the assessment of sperm-associated oocyte 
activation factor (Rybouchkin, Dozortsev, Pelinck, De Sutter, & Dhont, 1996) because they are tolerant to 
Ca2+ oscillation patterns (Ozil et al., 2005; Toth, Huneau, Banrezes, & Ozil, 2006). Parthenogenetic 
mouse oocyte activation relies on the calcium wave that generates the responses associated with 
fertilisation when calcium release reaches a certain threshold (Uranga, Pedersen, & Arechaga, 1996). 
Calcimycin also known as A23187 is a Ca2+-selective ionophore widely used as an oocyte activation 
agent (Kashir et al., 2010). It can induce Ca2+ influx by altering the plasma membrane permeability or 
acting directly on intracellular organelles that release Ca2+ (Mason & Grinstein, 1993; Morgan & Jacob, 
1994). 
 
Lastly, oxidative stress has been recognised as an important contributory factor to male infertility 
(Agarwal, Ahmad, & Sharma, 2015; Agarwal et al., 2014; Roychoudhury, Sharma, Sikka, & Agarwal, 
2016; Tremellen, 2008). In ICSI, seminal plasma is removed during semen processing, but toxic 
oxygen metabolites (generated by immature spermatozoa and leucocytes) might still attack the 
sperm devoid of protective seminal plasma antioxidants (Aitken & Baker, 1995; Zini, San Gabriel, 
& Baazeem, 2009). A new technique called MiOXSYS system allows the assessment of oxidation–
reduction potential (ORP). It provides a comprehensive measure of seminal oxidative stress and is 
indicative of the overall balance between all available oxidants and antioxidants in a given sample 
(Agarwal, Roychoudhury, Bjugstad, & Cho, 2016; Agarwal, Sharma, Roychoudhury, Du Plessis, & 
Sabanegh, 2016). To our knowledge, the ORP of spermatozoa selected for ICSI after exposure to 
PVP and HA has not been measured yet. 
 
 
To investigate these several events that take place prior to sperm injection, we conducted a series of 
experiments using both an ICSI experimental model and a new method for sperm selection. Our 
objectives were to assess (i) the activation of mouse oocytes after ICSI using human spermatozoa 
showing progressive motility with linear or rotational motion independent of the type of rotation 
(clockwise or anticlockwise); (ii) the activation of mouse oocytes after ICSI of human spermatozoa 
selected in PVP and HA microdroplets; (iii) the activation and embryo developmental competence of 
the parthenogenetically activated mouse oocytes after ICSI using PVP and HA; and lastly (iv) the 
ORP of human spermatozoa selected for ICSI after exposure to PVP and HA. These experiments 
will help answer if there is any advantage of using spermatozoa exhibiting rotational movement and 
answer the debate on the value of using PVP vis-a-vis the need to replace with HA for optimal 
selection of spermatozoa prior to ICSI. The measurement of ORP in prepared spermatozoa selected 
for ICSI following exposure to PVP or HA will further help identify the media with low oxidative 
stress. 
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2  |  Materials and Methods 
Following Institutional approval, discarded semen samples were used. All subjects provided a written 
informed consent. Frozen mouse oocytes were procured from a vendor (Embryotech, Haverhill, 
MA), and hence, no ethical clearance was necessary from the Institutional Animal Care and Use 
Committee. 
 
2.1 | Experiment 1. Activation of mouse oocytes after intracytoplasmic injection of 
human spermatozoa with linear and rotational motion 
Fresh human semen samples (n = 2) from fertile normozoospermic men according to 2010 
WHO guidelines and B6C3F1 frozen metaphase II mouse oocytes (n = 88; Embryotech, 
Haverhill, MA) were used in this experiment. Spermatozoa were prepared by the density 
gradient centrifugation with 40% and 80% gradients (Cooper Surgical, Trumbull, CT, USA) 
and selected for ICSI based on either linear or rotational motion in deep regions of a PVP 
(Origio, Denmark) microdroplet. Spermatozoa with linear motion were those that changed 
their position but not their location by exhibiting a clear two-dimensional movement in the 
bottom of a PVP droplet under inverted microscope (Leica Microsystems, Wetzlar, Germany) 
examination using a 40× objective. On the other hand, spermatozoa with rotational motion 
were the ones that changed position by gyrating over its own axis under the same 
aforementioned conditions (Figure 1). Frozen mouse oocytes were thawed, and the surviving 
oocytes (n = 81) were randomly assigned into two groups for microinjection. Spermatozoa 
with linear motion (Group 1; n = 39) and rotational motion (Group 2; n = 42) were selected 
and microinjected into the oocyte cytoplasm. In both cases, spermatozoa displaying 
progressive motility and rotational or linear motion were selected under 40× objective. 
Using the same magnification, selected spermatozoa were immobilised by squeezing the tail 
using the injection micropipette prior to injection. After sperm injections, the oocyte 
activation rates (recorded as a percentage of embryo development at the two-cell stage 24 hr 
after microinjection) were assessed (Figure 2). Culture was performed under standard 
culture conditions. 
 
2.2 | Experiment 2. Activation of mouse oocytes after intracytoplasmic injection of 
human spermatozoa selected in PVP and HA droplets 
Fresh human semen samples  (n = 2)  from  fertile  normozoospermic men according to 
2010 WHO guidelines and B6C3F1 frozen metaphase II mouse oocytes (n = 94) were 
used in this experiment. Spermatozoa prepared by the density gradient centrifugation 
were selected for ICSI in either a microdroplet of PVP (Origio, Denmark) or HA 
(SpermCatch, Nidacon, Sweden) or culture medium (Quinn’s Advantage medium with 
HEPES, Origio, Denmark; control). Similar to PVP, the HA-containing product slows 
sperm motility sufficiently for the spermatozoa to be captured with an injection 
pipette (Balaban et al., 2003). Surviving oocytes (n = 83) were randomised for ICSI 
according to the medium used for sperm selection: PVP (n = 28); HA (n = 27) and 
culture medium (control; n = 28). Sperm immobilisation and injection were carried 
out as described in experiment 1. After ICSI, the oocyte activation rates (recorded as a 
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percentage of surviving oocytes at the two-cell stage 24 hr after microinjection) were 
reported (Figure 3). 
 
2.3 | Experiment 3. Parthenogenetic activation and development competence of 
mouse oocytes after intracytoplasmic injection of PVP or HA 
B6C3F1 frozen metaphase II mouse oocytes (n = 116) were used in this experiment. 
Frozen mouse oocytes were thawed, and the surviving oocytes (n = 102) were randomised 
into three groups for microinjection: PVP-treated (n = 36); HA-treated (n = 34) and 
control (n = 32). In the respective groups, 2–3 picolitres of PVP, HA or culture medium 
was microinjected into the oocyte cytoplasm (Motoishi et al., 1996). Of note, no 
spermatozoa were injected. Immediately after microinjection, the oocytes were partheno-
genetically activated by exposure to a ready-to-use calcimycin (Ca2+-selective ionophore) 
A23187 solution (GM508 Cult-Active, Gynemed, Germany) for 15 min. The parthenogenetic 
activation of mouse oocytes and embryo development were recorded until the blastocyst stage 
(Figure 4). 
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2.4 | Experiment 4. Oxidation–reduction potential of human spermatozoa selected for 
ICSI after PVP or HA exposure 
Fresh human semen samples (n = 11) from normozoospermic men according to 2010 WHO 
guidelines were used in this experiment. Spermatozoa were prepared by density gradient 
centrifugation, and the washed sperm preparations were adjusted to 5 × 106 sperm/ml. A 
sperm aliquot was then loaded into a microdroplet of either PVP orHA or sperm wash 
medium in a 3:10 ratio (vol./vol.). The sORP (static ORP which refers to the passive or 
current state of activity between oxidants and antioxidants) was measured after 20 min and 1 
hr of exposure using a galvanostat-based technology—the MiOXSYS System (Aytu 
Bioscience, Englewood, CO) in triplicate at room temperature (Figure 5). The MiOXSYS 
system was calibrated prior to testing according to the manufacturer’s instructions. For 
analysing the sample, 30 μl of sperm suspension was applied to the sample application port 
on the inserted sensor. After 3–4 min, audible beeps indicated the completion of the test 
and the absolute value of sORP was displayed in millivolts or mV on the screen (Agarwal, 
Sharma, et al., 2016). The sORP value was then divided by sperm concentration to obtain 
normalised sORP, which was expressed as mV/106 sperm/ml. 
 
For all experiments, one well-trained scientist (SR) performed all sperm handling procedures 
whereas another proficient scientist (IMR) performed all injections. 
 
2.5  | Statistical analysis 
For experiments 1–3, chi-square or Fisher exact tests as appropriate were used to compare the 
outcome measures (expressed as mean ± 95% confidence interval) among the groups using an 
alpha level of p < .05. In experiment 4, the ORP data of human spermatozoa selected for 
ICSI after exposure to PVP, HA or culture medium were normalised as mV/106 sperm/ml and 
expressed as mean ± SD. In the latter, the paired t test was used to compare the groups and 
differences were considered statistically significant at a level p < .05. 
http://repository.uwc.ac.za
7 
 
3. | Results  
3.1 | Experiment 1. Activation of mouse oocytes after intracytoplasmic injection of human 
spermatozoa with progressive motility and either linear or rotational motion 
The oocyte activation rates following sperm selection by linear versus rotational motion are 
presented in Figure 6. The oocyte activation rate achieved in the group of rotational motion was 
79.2% compared to 52.3% (p = .05). 
 
3.2 | Experiment 2. Activation of mouse oocytes after intracytoplasmic injection of 
human spermatozoa selected in PVP or HA 
The rates of oocyte activation after intracytoplasmic injection of human spermatozoa selected in 
PVP, HA or culture medium (control) are presented in Figure 7. The oocyte activation rates were 
73.7% (14/19) in PVP group, 72.2% (13/18) in HA group and 75.0% (15/20) in the control group. 
These parameters were not significantly different among the groups. 
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3.3 | Experiment 3. Parthenogenetic activation and development competence of 
mouse oocytes after intracytoplasmic injection with PVP and HA 
The development competence of parthenogenetically activated mouse oocytes after 
intracytoplasmic injection of PVP, HA or culture medium is presented in Figure 8. The oocyte 
activation rates were not significantly different among the groups: 62.5% (15/24) in the PVP 
group, 68.0% (17/25) in the HA group and 61.9% (13/21) in the control group. Of the embryos that 
reached the two-cell stage in the PVP, HA and control groups respectively, 53.3% (8/15), 52.9% 
(9/17) and 53.8% (7/13) attained a four-cell stage. And among the embryos that reached the four-
cell stage in the respective aforementioned groups, 53.3% (8/15), 52.9% (9/17) and 46.1% (6/13) 
achieved the compacted morula stage. Lastly, on day 5 the blastocyst formation rates were 33.3% 
(5/15), 35.3% (6/17) and 38.5% (5/13) in the PVP, HA and control groups respectively. No 
significant differences were seen among the groups with regard to these outcome measures. 
 
3.4 | Experiment 4. Oxidation–reduction potential of human spermatozoa selected for 
ICSI after PVP and HA exposure 
The ORP of human spermatozoa selected for ICSI after exposure to PVP, HA or culture medium 
(control) is presented in Figure 9. The sORP levels differed significantly among the three groups both 
after 20 min and 1 hr of exposure (p < .0001). The lowest sORP levels were noted in the PVP-treated 
group followed by the HA-treated group and control group at both time points. Prior to any treatment 
with PVP or HA (Time 0), sORP level in the control group was 57.60 ± 0.63 mV/106 sperm/ml. After 
20 min of incubation in PVP, HA and culture media (control), sORP levels were 46.27 ± 1.96 mV/106 
sperm/ml (p < .0001), 50.88 ± 1.38 mV/106 sperm/ ml (p < .0001) and 57.49 ± 2.55 mV/106 
sperm/ml (p = .8909) respectively. These values did not change significantly after 1 hr of exposure and 
were 47.04 ± 1.01 mV/106 sperm/ml (p < .0001), 50.80 ± 1.23 mV/106 sperm/ml (p < .0001) and 57.30 
± 2.66 mV/106 sperm/ml (p = .7197) in PVP, HA and control groups respectively. However, 
compared to the readings after 20 min, sORP values did not change in PVP (p = .1020), HA (p = .6918) 
and the control groups (p = .4761) after 1 hr. 
 
 
http://repository.uwc.ac.za
9 
 
 
 
4  |  Discussion 
Increased oocyte activation rates were achieved when mouse oocytes were injected with human 
spermatozoa exhibiting progressive motility and rotational motion over those with linear motion, 
suggesting that the mode of sperm movement at the time of selection might enhance sperm 
selection and influence ICSI outcome. Miki and Clapham (2013) proposed that rheotaxis, that is a 
taxis whereby an organism is turning into an oncoming current, is a major determinant of sperm 
guidance over long distances in the female reproductive tract. Moreover, sperm rheotaxis requires 
rotational motion. The tendency of human spermatozoa to exhibit rotational movement increases 
with the viscosity of the media, which dampens the strong transverse component and enables 
spermatozoa to more closely approach to, and align with the surface (Nosrati et al., 2015). Moreover, 
in ICSI where sperm quality is one of the decisive factors to oocyte fertilisation, embryo 
development, and implantation, distinguishing spermatozoa on the basis of beat frequency above 
5.6 Hz has been suggested as an important tool in sperm sorting and selection (Subramani et al., 
2014). To our knowledge, our study is the first to examine under a regular inverted microscope and 
into PVP droplet prior to injection the effect of sperm selection based on the linear or rotational 
motion characteristics. The biological plausibility of our findings is in accordance to the type of 
sperm movement found in the highly viscous fluid of confined regions of the fallopian tube 
(Nosrati et al., 2015). 
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Our findings indicated a higher oocyte activation using spermatozoa with rotational motion 
than linear motion with an absolute difference of 27%, which seems clinically important. 
However, given the small sample size and only marginally significant differences further 
studies are needed both in animal and human models to validate our results and to 
determine whether they translate in an improvement in other clinical outcomes. 
 
We found that oocyte activations rates (recorded as the percentage of embryos at the two-cell 
stage 24 hr after microinjection) were unaffected by the type of media, namely, PVP or HA, 
used for sperm handling before microinjection. 
 
Nevertheless, the literature is mixed with regard to the use of PVP- and HA-based medium 
for sperm handling prior to ICSI (Balaban et al., 2003; Choe et al., 2012; Ebner, Filicori, 
Tews, & Parmegiani, 2012; Majumdar & Majumdar, 2013; Parmegiani, Cognigni, Bernardi, 
et al., 2010). In one study, Choe and colleagues suggested that ICSI outcomes are not related 
to the type of media used for sperm selection (Choe et al., 2012). The aforementioned 
authors enrolled 219 couples in which oocytes were injected with sperm selected either in 
PVP (n = 112) or HA (n = 107), and no significant differences were observed between the two 
groups in terms of fertilisation, cleavage and blastocyst formation. 
http://repository.uwc.ac.za
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However, cleavage rates on day 3 were significantly lower (p = .038) in the HA group than the PVP 
group (Choe et al., 2012). In another study, Balaban et al. (2003) compared the outcomes of 
ICSI in 92 couples using PVP- (n = 44) and HA-selected (n = 48) spermatozoa and reported similar 
rates of fertilisation, cleavage, good quality embryos, clinical pregnancy and implantation. 
Despite that, the authors advocated the use of HA as an effective and more physiologic alternative to 
PVP to modulate sperm motility prior to aspirating a single spermatozoon into an ICSI pipette. 
Barak and coworkers also found similar rates of fertilisation, clinical pregnancy, implantation and 
live birth in 123 couples subjected to ICSI with spermatozoa selected in PVP (n = 65) or HA (n = 58) 
(Barak et al., 2001). Despite not finding any significant difference in ICSI outcomes, these authors 
commented that HA was a viable substitute to PVP based on the fact that it is a natural and readily 
degradable substance. These aforementioned results have been corroborated by recent studies 
(Majumdar & Majumdar, 2013; Parmegiani, Cognigni, Bernardi, et al., 2010). On the contrary, Nasr-
Esfahani et al. reported higher fertilisation rates (79.4% vs. 67.7%; p = .02) in the HA group 
http://repository.uwc.ac.za
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compared to the PVP group, albeit the number of embryos generated, the percentages of cleavage 
and good quality embryo were not significantly different between the two groups on days 2 and 3 
post-ICSI. Added to this, implantation rates and clinical pregnancy rates were not significantly 
different in this study (Nasr-Esfahani, Deemeh, & Tavalaee, 2010). In a randomised control study, 
PVP and HA selection of spermatozoa was compared in 206 infertile couples treated by ICSI 
(Parmegiani, Cognigni, Bernardi, et al., 2010). The authors found that HA favoured sperm selection 
with lower levels of DNA fragmentation, as indicated by the sperm chromatin dispersion test, which 
might explain the higher proportion of embryos classified as having high quality (35.8% vs. 
24.1%; p = .04) as well as the overall embryo development rate (95% vs. 84%; p ≤ .001) in HA-
treated specimens. However, these differences did not translate in any improvement in other 
clinical outcomes, including fertilisation rates, clinical pregnancy, implantation and live birth rates. 
The same group retrospectively analysed data from 86 infertile couples treated with PVP-ICSI and 
293 couples with HA-ICSI in the same year and concluded that the proportion of embryos classified 
as having high quality (35.2% vs. 22.3%; p = .01) and implantation rates (17.1% vs. 10.3%; p = .04) 
were higher in the HA group than the PVP group, even though no significant differences were 
observed in fertilisation rates, clinical pregnancy and live birth rates (Parmegiani, Cognigni, 
Ciampaglia, et al., 2010). 
 
During ICSI, spermatozoa treated with the PVP solution can be easily immobilised by a light touch 
of the tail with a glass micropipette (Tsai et al., 2000). However, motility is resumed once spermatozoa 
are transferred to a normal culture medium (Dozortsev et al., 1995) if their tails are not completely 
broken, which might compromise oocyte activation. This indirect negative effect of PVP on sperm 
immobilisation has been suggested to be responsible for the decreased fertilisation rates shown in 
some studies rather than an arguable toxicity of PVP (Dozortsev et al., 1995).On the one hand, it 
has been proposed that sperm selection using HA is advantageous to prevent fertilisation of oocytes 
with DNA-damaged and chromosomal-unbalanced spermatozoa, which seems to be particularly 
relevant when specimens containing high proportion of defective spermatozoa are available for ICSI 
(Ebner et al., 2012). But the same might not be true when specimens taken from men with normal 
sperm parameters were used, as shown in our study. Furthermore, the ability of HA to deselect 
spermatozoa with damaged DNA is not unequivocal as recently shown (Huang et al., 2015). 
 
The mouse oocyte activation test is a useful heterologous ICSI model to assess the impact of PVP 
and HA on oocyte activation while controlling for the sperm factor (Heindryckx, De Gheselle, 
Gerris, Dhont, & De Sutter, 2008; Heindryckx, Van Der Elst, De Sutter, & Dhont, 2005; 
Rybouchkin et al., 1996; Tesarik, Rienzi, Ubaldi, Mendoza, & Greco, 2002a,b). Calcium 
signalling is crucial for oocyte activation and further embryonic development (Ducibella, 
Schultz, & Ozil, 2006; Kline & Kline, 1992; Marangos & Carroll, 2004; Ozil, Banrezes, Toth, 
Pan, & Schultz, 2006). An increase in fertilisation and cleavage-stage embryo rates with the 
use of assisted oocyte activation protocols involving the use of Ca2+-ionophores has also been 
reported (Ebner et al., 2012; Heindryckx et al., 2008; Nikiforaki et al., 2016; Sfontouris et 
al., 2015; Vanden Meerschaut, Nikiforaki, Heindryckx, & De Sutter, 2014). 
 
This aforementioned model seems ideal to investigate whether PVP is toxic to oocytes and 
embryos. This is important because a small amount of PVP is unavoidably injected into the 
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oocyte during sperm injections. Moreover, it has been suggested that PVP delays calcium 
oscillation in sperm-penetrated oocytes and prevents nuclear decondensation (Clarke & 
Johnson, 1988; Dozortsev et al., 1995). Added to this, PVP is suggested to be associated with 
impaired two-cell mouse embryos development (Bergers et al., 1993) by exerting toxicity to 
mouse zygotes (Bras, 1994). While comparing ICSI outcomes after sperm selection in PVP 
or culture medium, Tsai et al. (2000) reported improved fertilisation rate (84.43% vs. 57.63%; 
p < .001) and embryo grading (χ2 = 6.80; p = .009) in the group where spermatozoa had 
been selected in the culture medium. Despite suggesting that elimination of PVP might be 
responsible for the observed improved fertilisation rate, these authors cautioned that other 
factors could be involved, including sperm factors. On the contrary, it has also been suggested 
that the biochemical and molecular parameters of developmental maturity displayed by 
spermatozoa selected in HA instead of PVP play a critical role in the paternal contribution to 
successful pre-implantation embryogenesis (Worrilow et al., 2013). 
 
In our study, the metaphase II mouse oocytes were injected with PVP, HA or culture 
medium similar to a normal ICSI procedure. Oocytes were then activated 
parthenogenetically by exposure to a ready-to-use calcimycin (Ca2+-selective ionophore) 
A23187 solution. Parthenogenetic oocyte activation and embryo development competence 
were recorded until blastocyst stage, and no significant differences among the PVP-treated, 
HA-treated and the control groupswere observed in oocyte degeneration rate, two- and 
four-cell embryo formation rate, compacted morula stage and blastocyst formation rate. To 
our knowledge, our results are novel in demonstrating that PVP and HA have similar effects 
on parthenogenetically activated mouse oocytes, adding confidence to the continued use of 
PVP in routine ICSI practice. The validation of our results using human oocytes is nevertheless 
required. 
 
Seminal plasma is removed during semen processing for IVF and ICSI, and therefore, toxic 
oxygen metabolites (generated by immature sperm and residual leucocytes) may attack 
spermatozoa lacking the protection of seminal plasma antioxidants. As a matter of fact, the 
detrimental effect of oxidative stress on sperm functional competence can be further 
exaggerated by the in vitro sperm processing techniques, including density gradient 
centrifugation and prolonged incubation (Aitken & Baker, 1995; De Iuliis et al., 2009; Zini et 
al., 2009), which might lead to sperm dysfunction and DNA damage (Aitken, De Iuliis, Finnie, 
Hedges, & Mclachlan, 2010; Chen et al., 2012; Tremellen, 2008). The ORP is a comprehensive 
measure of oxidative stress as it provides the overall balance between all available oxidants 
and antioxidants in a given sample. Static ORP measures the current state of activity between 
oxidants and antioxidants, and it has been recently suggested that sORP of human 
spermatozoa could be potentially useful to predict ART outcomes, to monitor antioxidant levels 
and to identify infertile men who may benefit from antioxidant therapy as well as treatment 
monitoring (Agarwal, Roychoudhury, et al., 2016). 
 
In our study, levels of sORP in human spermatozoa selected for ICSI were lower in the 
PVP-treated group than in the HA-treated group and the control group. These findings 
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are also novel and suggest that PVP might alleviate sperm oxidative stress as it contains a 
synthetic serum replacement that acts as a chelating agent (Bavister, 1995; Nielsen & 
Bertheussen,1991). This could be advantageous in the context of male factor infertility, as 
spermatozoa of infertile men usually have elevated oxidative stress. Of note, exposure of 
spermatozoa to hyaluronic acid alone has not shown to induce acrosome reaction (Hong et 
al., 2009; Sabeur, Cherr, Yudin, & Overstreet, 1998). This is important because the acrosome 
reaction increases the production of ROS and would introduce a bias in our experiments. As 
shown in our experiment, the sORP levels remained unchanged after both short and 
prolonged sperm exposure to HA, thus adding confidence to our results. Our findings using 
a mouse model support the continued use of PVP for sperm selection and manipulation in 
ICSI processes. Notwithstanding, confirmatory experiments involving spermatozoa from 
infertile men are needed. Also important would be the assessment of the embryo 
development and implantation potential of resulting embryos from sperm populations 
exposed to variable time in PVP and HA and with measurable sORP levels. 
 
5  |  Conclusions 
This series of experiments using an experimental ICSI model with mouse oocytes provides 
novel findings that add to the understanding of the sperm handling and selection step that 
precedes the sperm injection. For the first time, we demonstrated the selection of human 
spermatozoa with rotational motion as a novel indicator of sperm quality and it might also 
have the potential to improve ICSI outcome. Second, similar oocyte activation rates were 
achieved when spermatozoa were selected in a PVP- or HA-based medium. Third, we have 
shown in an experiment controlling for sperm factors that neither PVP nor HA seems to 
adversely affect development competence of parthenogenetically activated mouse oocytes. 
Lastly, measurement of sORP on washed spermatozoa selected for ICSI after exposure to PVP 
and HA revealed that the lowest levels of oxidative stress are found in spermatozoa selected 
in the PVP-based medium, thus suggesting possible antioxidant properties of PVP. 
Importantly, the results of the parameters analysed support the continued clinical use of 
PVP for selection and manipulation in ICSI processes. 
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